Impaired expression of IgA Fc receptors (CD89) by blood phagocytic cells in ankylosing spondylitis

Journal of Rheumatology

Volumn 27, Issue 2, 2000, Pages 411-417

  Montenegro, Viviane ^a   Chiamolera, Murilo ^b   Launay, Pierre ^b   Gonçalves, Célio R ^b   Monteiro, Renato C ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

Fc Receptor; IgA; Phagocytes; Spondyloarthropathy

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN A; PREDNISONE;

ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; BINDING SITE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; MALE; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR OCCUPANCY;

ADULT; ANTIGENS, CD; DOWN-REGULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; NEUTROPHILS; RECEPTORS, FC; SPONDYLITIS, ANKYLOSING;

EID: 0033962662     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Khan MA, editor. Spondyloarthropathies. Rheum Dis Clin North Am 1992;18:1-276.
2. Calin A, Taurog JD, editors. The spondylarthritides. Oxford: Oxford University Press; 1997.
3. Rubin LA, Amos CI, Wade JA, et al. Investigating the genetic basis for ankylosing spondylitis: linkage studies with the major histocompatibility complex region. Arthritis Rheum 1994;37:1212-20.
4. Van der Linden SM, Valkenbrug HA, De Jongh B, Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: a comparison on relatives of spondylitis patients with the general population. Arthritis Rheum 1984;3:241-9.
5. Lipsky PE, Taurog JD. The Second International Simmons Center Conference on HLA-B27-related disorders. Arthritis Rheum 1991;34:1476-82.
6. 2m: An animal model of HLA-B27-associated human disorders. Cell 1990;63:1099-112.
7. Taurog JK, Richardson JA, Croft JT, et al. The germ free state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic mice. J Exp Med 1994;80:2359-64.
8. 2 microglobulin: a model of human spondyloarthopathies. J Exp Med 1995;182:1153-8.
9. Hocini H, Iscaki S, Benlahrache C, et al. Increased levels of serum IgA as IgA1 monomers in ankylosing spondylitis. Ann Rheum Dis 1992;51:790-2.
10. Feltelius N, Hvatum M, Brandtzeg P, Knutson L, Hällgren R. Increased jejunal secretory IgA and IgM in ankylosing spondylitis: normalization after treatment with sulfasalazine. J Rheumatol 1994;21:2076-81.
11. Mäki-Ikola O, Nissilä M, Lehtinen K, Leirisalo-Repo M, Granfors K. IgA1 and IgA2 subclass antibodies against Klebsiella pneumoniae in the sera of patients with peripheral and axial types of ankylosing spondylitis. Ann Rheum Dis 1995;54:631-5.
12. Tani Y, Sato H, Tanaka N, Mori K, Doida Y, Hukuda S. Serum IgA1 and IgA2 subclass antibodies against collagens in patients with ankylosing spondylitis. Scand J Rheumatol 1997;26:380-2.
13. Tani Y, Tiwana H, Hukuda S, et al. Antibodies to Klebsiella, Proteus and HLA B27 peptide in ankylosing spondylitis and rheumatoid arthritis. J Rheumatol 1997;24:109-14.
14. Cowling P, Ebringer R, Ebringer A. Association of inflammation with raised serum IgA in ankylosing spondylitis. Ann Rheum Dis 1980;39:545-9.
15. Calguneri M, Swinburne L, Shinebaum R, Cooke EM, Wright V. Secretory IgA: immune defense pattern in ankylosing spondylitis and klebsiella. Ann Rheum Dis 1981;40:600-4.
16. Hunter H, Harding GKM, Kaprove RE, Schoroeder ML. Fecal carriage of various klebsiella and enterobacter species in patients with active ankylosing spondylitis. Arthritis Rheum 1981;24:106-8.
17. Franssen J, Van de Putte LB, Gribnau FW. IgA serum levels and disease activity in ankylosing spondylitis: a prospective study. Ann Rheum Dis 1985;44:766-71.
18. Collado A, Sanmartí R. Brancós MA, et al. Immunoglobulin A and C-reactive protein levels in ankylosing spondylitis. Ann Rheum Dis 1987;46:719-20.
19. Gratacós J, Collado A, Filella X, et al. Serum cytokines (IL-6, TNF-α, IL-1 and IFN-γ) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 1994;10:927-31.
20. Jennette JC, Ferguson AL, Moore MA, Freeman DG. IgA nephropathy associated with seronegative spondyloarthropathies. Arthritis Rheum 1982;25:144-9.
21. Shu KH, Lian JK, Yang YF, et al. Glomerulonephritis in ankylosing spondylitis. Clin Nephrol 1986;25:169-79.
22. Bruneau C, Villiaumey J, Avouac B, et al. Seronegative spondyloarthropathies and IgA glomerulonephritis: a repon of 4 cases and a review of literature. Semin Arthritis Rheum 1986;15:79-184.
23. Chen A, Ho Y-S, Tu Y-C, Shieh S-D, Hung H-W, Chou C-T. Immunoglobulin A nephropathy and ankylosing spondylitis. Report of two cases in Taiwan and review of literature. Nephron 1988;49:313-8.
24. Andersen GN. IgA nephropathy in a patient with ankylosing spondylitis. Scand J Rheumatol 1992;21:46-7.
25. Beauvais C, Kaplan G, Mougenot B, Michel C, Marinho E. Cutaneous vasculitis and IgA glomerulonephritis in ankylosing spondylitis. Ann Rheum Dis 1993;52:61-2.
26. Gratacós J, Collado A, Sanmartí R, Poch E, Torras A, Muñoz-Gomez J. Coincidental amyloid nephropathy and IgA glomerulonephritis in a patient with ankylosing spondylitis. J Rheumatol 1993;20:1613-5.
27. Collado A, Sanmarti R, Bielsa I. Immunoglobulin A in the skin of patients with ankylosing spondylitis. Ann Rheum Dis 1988;47:1004-7.
28. Warmold A, van den Wall Bake L, Peeters AJ, et al. Immunoglobulin synthesis by peripheral blood lymphocytes in patients with ankylosing spondylitis. J Rheumatol 1988;15:1410-44.
29. Peeters A, Daha M, Smeets TJM, Breedveld MD. Bone marrow IgA and IgA subclass synthesis in ankylosing spondylitis. J Rheumatol 1992;19:751-3.
30. Stockert RJ, Kressner MS, Collins JC, Sternlieb I, Morell AG. IgA interaction with the asialoglycoprotein receptor. Proc Natl Acad Sci USA 1982;79:6229-31.
31. Monteiro RC, Kubagawa H, Cooper MD. Cellular distribution, regulation, and biochemical nature of an Fc receptor in humans. J Exp Med 1990;171:597-613.
32. Maliszewski CR, March CJ, Schoenborn MA, Gimpel S, Shen L. Expression cloning of a human Fc receptor for IgA. J Exp Med 1990;172:1665-72.
33. Monteiro RC, Hostoffer RW, Cooper MD, Bonner JR, Gartland GL, Kubagawa H. Definition of immunoglobulin-A receptors on eosinophils and their enhanced expression in allergic individuals. J Clin Invest 1993;92:1681-5.
34. Pfefferkorn LC, Yeaman GR. Association of IgA-Fc receptors (FcαR) with FceRIg2 subunits in U937 cells - aggregation induces the tyrosine phosphorylation of γ2. J Immunol 1994;153:3228-36.
35. Launay P, Patry C, Lehuen A, Pasquier B, Blank U, Monteiro RC. Alternative endocytic pathway for IgA Fc receptors (CD89) depends on the lack of FcRγ association and protects against degradation of bound ligand. J Biol Chem 1999;274:7216-25.
36. Patry C, Herbelin A, Lehuen A, Bach JF, Monteiro RC. Fcα receptors mediate release of tumour necrosis factor-α and interleukin-6 by human monocytes following receptor aggregation. Immunology 1995;86:1-5.
37. Morton HC, van Egmond M, van de Winkel JGJ. Structure and function of human IgA Fc receptors (FcR). Crit Rev Immunol 1996;116:423-40.
38. Roccatello D, Picciotto G, Torchio M. et al. Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients - the role of asialoglycoprotein receptors. Lab Invest 1993;69:714-23.
39. Monteiro RC, Grossetête B, Nguyen AT, Jungers P, Lehuen A. Dysfunctions of Fcα receptors by blood phagocytic cells in IgA nephropathy. Contrib Nephrol 1995;111:116-22.
40. Grossetête B, Viard JP, Lehuen A, Bach JF, Monteiro RC. Impaired Fcα receptor expression is linked to increased immunoglobulin A levels and disease progression in HIV-1-infected patients. AIDS 1995;9:229-34.
41. Silvain C, Patry C, Launay P, Lehuen A, Monteiro RC. Altered expression of monocyte IgA Fc receptors is associated with defective endocytosis in patients with alcoholic cirrhosis - potential role of IFN-γ. J Immunol 1995;155:1606-18.
42. Grossetête B, Launay P, Lehuen A, Jungers P, Bach JF, Monteiro RC. Down-regulation of Fc receptors on blood cells of IgA nephropathy patients: evidence for a negative regulatory role of serum IgA. Kidney Int 1998;53:1321-35.
43. Moll JMH, Wright V. New York clinical criteria for ankylosing spondylitis. Ann Rheum Dis 1973;32:354-63.
44. Arnett FC, Edworthy S, Bloch DA, et al. The 1987 revised ARA criteria for rheumatoid arthritis [abstract]. Arthritis Rheum 1987;30 Suppl:S17.
45. Monteiro RC, Cooper MD, Kubagawa H. Molecular heterogeneity of Fc receptors detected by receptor-specific monoclonal antibodies. J Immunol 1992;148:1764-70.
46. Bunce M, O'Neill CM, Barnardo MCNM, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995;46:335-67.
47. Laemmli UK. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 1970;277:680-5.
48. MacLean IL, Archer JR, Cawley MID, et al. Immune complexes in ankylosing spondylitis. Ann Rheum Dis 1992;51:83-6.
49. Moller P, Kleeland G, Egeland T, Vinje O, Mellbye OJ. IgA and rheumatoid factor in ankylosing spondylitis. Scand J Rheumatol 1988;75 Suppl:276-7.
50. Montenegro V, Monteiro RC. Elevation of serum IgA in spondyloarthropathies and IgA nephropathy and its pathogenic role: a review. Curr Opin Rheumatol: 1999;11:265-72.
51. Ghetie V, Hubbard JG, Kim JK, Tsen MF, Lee Y, Ward ES. Abnormally short serum half-lives of IgG in B2-microglobulin deficient mice. Eur J Immunol 1996; 26:690-6.
52. Junghans RP, Anderson CL. The protection receptor for IgG catabolism is the B2-microglobulin-containing neonatal intestinal transport receptor. Proc Natl Acad Sci USA 1996;93:5512-6.
53. Luan JJ, Monteiro RC, Sautes C, et al. Defective FcgRII gene expression in macrophages of NOD mice: Genetic linkage with upregulation of IgG1 and IgG2b in serum. J Immunol 1996; 157:4707-16.
54. Reterink TJ, Levarht EW, Klar-Mohamad N, Van Es LA, Daha MR. Transforming growth factor-beta 1 (TGF-β1) down regulates IgA Fc-receptor (CD89) expression on human monocytes. Clin Exp Immunol 1996;103:161-6.
55. Braun J, Bollow M, Neure L, et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biosy specimens from patients with ankylosing spondylitis. Arthritis Rheum 1995;38:499-505.
56. Lefebvre JC, Giordanengo V, Limouse M, et al. Altered glycosylation of leukosialin, CD43, in HIV1-infected cells of the CEM line. J Exp Med 1994;180:1609-17.
57. van Liebergen FJHM, Assmann KJM, Koene RAP, van de Putte LBA. IgA nephropathy and ankylosing spondylitis. Kidney Int 1983;24:408.
58. Peeters AJ, van den Wall Bake AWL, van Albada-Kuipers GA, van Es LA, Cats A. IgA containing immune complexes and hematuria in ankylosing spondylitis. A prospective longitudinal study. J Rheumatol 1988;15:1662-7.
59. Conley ME, Cooper MD, Michael F. Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest 1980;66:1432-6.
60. Van den Wall Bake AW, Daha MR, Haaijman J, Radl J, Van der Ark A, van Es LA. Elevated production of polymeric and monomeric IgA1 by the bone marrow in IgA nephropathy. Kidney Int 1989;35:1400-4.
61. Noel LH, Descamps B, Jungers P, et al. HLA antigen in three types of glomerulonephritis. Clin Immunol Immunopathol 1978;10:19-23.
62. Richman AV, Mahoney J, Fuller TJ. Higher prevalence of HLA-B12 in patients with IgA nephropathy. Ann Intern Med 1979;90:201.
63. Freedman BI, Spray BJ, Heise ER. HLA associations in IgA nephropathy and focal and segmental glomerulosclerosis. Am J Kidney Dis 1994;23:352-7.
64. Schwimmbeck PL, Yu DT, Oldstone MBA. Autoantibodies to HLA B27 in the serum of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. Molecular mimicry with Klehsiella pneumoniae as potential mechanisms of autoimmune disease. J Exp Med 1987;166:173-81.
65. Herrero-Beaumont G, Armas JB, Elswood J, Will RK, Calin A. Selective IgA deficiency and spondyloarthropathy: a distinct disease? Ann Rheum Dis 1990;49:636-7.
66. Russell MW, Sibley DA, Nikolova EB, Tomana M, Mestecky J. IgA antibody as a non-inflammatory regulator of immunity. Biochem Soc Trans 1997;25:466-70.